Categories AlphaGraphs, Earnings
United Parcel Service (UPS) tops Q3 earnings view, misses revenue targets
United Parcel Service’s (NYSE: UPS) Q3 earnings exceeded the market’s expectations, while revenue fell short of the consensus views. The logistics firm reported adjusted EPS of $2.07, up 14% and revenue of $18.32 billion, which grew 5% in the third quarter of 2019. Analysts had projected UPS to earn $2.06 per share on revenue of $18.35 billion. The company also reiterated its FY19 adjusted EPS outlook. UPS stock slid about 3% in the pre-market trading hours.
Earnings Infographic of UPS Q3 results
On a GAAP basis, UPS posted a profit of $2.01 per share, up 16% from last year’s third quarter. Operating profit growth of more than 20% in the recently ended quarter was led by the U.S. Domestic and International segments. U.S. Domestic segment had volume gains across all products.
In the U.S. Domestic segment, total volume across all products grew more than 9%. Next Day Air increased nearly 24%; Deferred Air grew more than 17%; and Ground volume rose nearly 7%. Growth came from both B2C and B2B shippers, led by the retail, healthcare and high-tech sectors.
The Atlanta, Georgia-based firm reiterated its fiscal year 2019 adjusted EPS guidance of $7.45 to $7.75, which assumes no further deterioration regarding global trade uncertainty or U.S. industrial weakness. Adjusted free cash flow for the full-year is projected to be over $4 billion.
“As we recently announced, we continue to forge new partnerships and create innovative solutions to accelerate growth in the most attractive opportunities,” said CEO David Abney.
UPS also announced today that its Chief Operating Officer will retire at the end of December 2019.
UPS stock has gained 22% since the beginning of this year and 2% from this time last year.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company